1 Min Read
BRUSSELS, Jan 15 (Reuters) - Galapagos NV : * Galapagos buys Cangenix, a structure-based drug discovery company * Says will pay a total cash consideration of 1 million pounds, with a further
440,000 pounds potential earn out payment
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.